NCT06958627View on ClinicalTrials.gov

The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

964

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2027

Conditions
HER2 Positive Breast CancerPyrotinib Treatment
Interventions
DRUG

pyrotinib

Intelligent patient management system on medication adherence of HER2 positive breast cancer patients receiving pyrotinib treatment.

Trial Locations (1)

100021

RECRUITING

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER